Related Experiment Video
Updated: Feb 9, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression
Wang Jiashi1, Qiu Chuang1, Zhang Zhenjun1
1Department of Orthopedic Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China.
Abstract:
Osteosarcoma is an aggressive bone tumor primarily affecting children and adolescents. Its cause is not yet fully understood, and there is an urgent need for more effective treatment. In the present study we identified several miRNAs whose expression is altered in osteosarcoma compared to adjacent normal tissue. Moreover, expression levels of one of those miRNAs, miR-506-3p, correlated negatively with expression of RAB3D (a Ras-related protein). Suppression of miR-506-3p in osteosarcoma led to increased expression of RAB3D, which in turn led to increased CDK4 (cyclin-dependent kinase 4) and MMP9 (matrix metalloprotein 9) activities. Our results suggest that miR-506-3p acts as a tumor suppressor in osteosarcoma and that its downregulation leads to tumor cell proliferation and metastasis due to upregulation of RAB3D- and CDK4-mediated signaling. miR-506-3p thus appears be a potentially useful target for adjuvant therapy in osteosarcoma patients.
Insights
MicroRNAs (miRNAs) are key in osteosarcoma. This study found miR-506-3p acts as a tumor suppressor by inhibiting RAB3D, CDK4, and MMP9, suggesting it as a therapeutic target for this aggressive bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma is an aggressive bone cancer in children and adolescents with unknown causes.
- There is a critical need for novel and effective therapeutic strategies against osteosarcoma.
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
Purpose of the Study:
- To identify specific miRNAs dysregulated in osteosarcoma tissues.
- To investigate the functional role of miR-506-3p in osteosarcoma pathogenesis.
- To explore the potential of miR-506-3p as a therapeutic target for osteosarcoma.
Main Methods:
- Differential expression analysis of miRNAs in osteosarcoma versus normal adjacent tissues.
- In vitro experiments to assess the effects of miR-506-3p suppression on gene expression and cell activities.
- Correlation analysis between miRNA expression and target gene (RAB3D) expression.
Main Results:
- Several miRNAs showed altered expression in osteosarcoma.
- miR-506-3p expression negatively correlated with RAB3D expression.
- Suppression of miR-506-3p increased RAB3D, CDK4, and MMP9 activities, promoting proliferation and metastasis.
Conclusions:
- miR-506-3p functions as a tumor suppressor in osteosarcoma.
- Downregulation of miR-506-3p contributes to osteosarcoma cell proliferation and metastasis via RAB3D/CDK4 signaling.
- miR-506-3p represents a promising target for adjuvant therapy in osteosarcoma.
Related Concept Videos
MicroRNAs
MicroRNAs
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

